Status:

ACTIVE_NOT_RECRUITING

Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study

Lead Sponsor:

St. Justine's Hospital

Collaborating Sponsors:

Centre hospitalier de l'Université de Montréal (CHUM)

Canadian Institutes of Health Research (CIHR)

Conditions:

Prematurity; Extreme

Eligibility:

All Genders

18-40 years

Brief Summary

Every year in Canada, 1500 babies are born ≤29 weeks' gestational age (GA) and the majority survive to adulthood. Preterm birth occurs during a critical period of nephrogenesis. Antenatal and postnata...

Detailed Description

Given that preterm birth is associated with reduced nephron endowment and higher glomerular area on renal histology suggesting compensatory glomerular hyperfiltration, we postulate that : Hypothesis ...

Eligibility Criteria

Inclusion

  • Born preterm ≤29 weeks or full-term at 37-41 weeks;
  • For full-term controls only, birthweight ˃2500g;
  • Aged 18-40 years;
  • Participants with type-2 diabetes can be included.

Exclusion

  • Currently pregnant due to administration of radionucleotides and impact on GRF,
  • Severe neurosensory deficit preventing test completion,
  • History of characterized kidney disease independent of preterm birth, including type-1 diabetes, glomerulopathies (e.g. nephrotic syndrome, glomerulonephritis), polycystic kidney disease, polycystosis, severe uropathy (Grade 4 or 5 RVU, severe hydronephrosis (SFU IV and V), posterior valve history), history of nephrectomy, exposure to radiotherapy or chemotherapy - given that we are interested in isolating the effects of preterm birth and that prevalence of these conditions is not increased in individuals born preterm,
  • In case of contra-indication to MRI scanning (which should be rare in the young population studied), the participant will still be given the opportunity to complete the other examinations.

Key Trial Info

Start Date :

June 26 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 30 2025

Estimated Enrollment :

157 Patients enrolled

Trial Details

Trial ID

NCT04735315

Start Date

June 26 2021

End Date

December 30 2025

Last Update

July 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

StJustine's Hospital

Montreal, Quebec, Canada, H3T 1C5